02 / Venture building
Venture Studio
Agentic Innovation Platform — applied to regulated venture building
For founders building in life sciences and digital health, the Agentic Innovation Platform compresses the cycle from idea to investible asset. GxP-compliant from inception. Regulatory-aware by design. Founders own the platform outright by month twelve.
Live demo · Venture Studio
Agentic harness · session-0042
AUDIT TRAIL · APPEND-ONLY
- T+0:00:00intentParsed founder briefBRIEF-0001OK
- T+0:00:12regulatoryTagged QbD risk registerQBD-RR-0001OK
- T+0:00:24evidenceDrafted predicate analysisPRED-0002REVIEW
COMPLIANCE STATE
- GxP
- ENFORCED
- QbD register
- LIVE
- PCCP scaffold
- DRAFT
- Citation guard
- ON
IP OWNERSHIP
Month 4 of 12 · transfers in full at month twelve.
Indicative trace. The production platform’s audit trail is cryptographically attested and submission-ready.
A working studio, instrumented from day one
The Venture Studio runs the agentic platform configured for the work of starting and translating a regulated company. It assembles regulatory evidence continuously as the science progresses. It maintains a queryable audit trail across every design decision, test outcome, and submission artifact. It handles adaptive-algorithm change management compatible with the FDA’s Predetermined Change Control Plan and the emerging MHRA AI Airlock pathway.
This is not a wrapper over an LLM. It is an agentic system designed for the constraints of regulated translation, built from the ground up to satisfy auditability requirements that off-the-shelf AI tools cannot meet.
Founders own the platform
By month twelve, the venture operates the platform independently. The IP transfers fully — no Limoja claim, no licence-back, no royalty. We measure success not by how long a venture depends on us, but by how cleanly it doesn’t.